Capital Roundtable

Marquee Sponsors

Association Partners

Data Partners

Partial List of
Past Attendees

Archimedes Health

Atalaya Capital Mgmt.

Avalon Net Worth

Baker Tilly

Barnes & Thornburg


Blue Wolf Capital

Brookwood Assocs.

Brown Gibbons Lang

Cain Brothers

Caisse de Depot et Placement du Quebec

Cantor Fitzgerald

Capitol Anesthesiology

Community Behavioral Health Center

Consonance Capital

Delta G Bio Corp. Dev.

Dental Care Alliance

England & Co.

Epstein Becker

Fidus Investment

Gieszl Firm

GPB Capital Holdings

Grant Thornton

Halyard Capital Mgmt.

Harbour Point Capital

Hellman & Friedman

Holland & Knight

HT Developers

Juna Equity Partners

Lead Capital Partners

Macquarie Capital

MDG Advertising

Michael Kelly Assocs.

New York Bariatric

NorthStar Anesthesia

OMERS Private Equity

OPSEU Pension Trust

Palladium Equity

Parkstone Growth

Plante Moran

Post Capital Partners

Pouschine Cook

Raymond James

RBC Capital Markets

Revelstoke Capital

River Cities Capital

Riverside Company

Seven Hills Capital

Sprout Health Group

Temasek International

TerraNova Capital

Unified Physician Management

Varsity Healthcare


WV Eye Consultants

Balancing the Attractions of

Specialty Physician Practices Against

The Logjams of Variety & Complexity


 Private Equity Investing

In Specialty Physician Practices



Justin Unertl


Excellere Partners


Thursday, August 2, 2018

8:00 am – 5:00 pm

New York City





McKinsey & Company

Plante Moran

Proskauer Rose


Fritz Buerger, William Blair & Co. LLC

Andrew R. Colbert, B. C. Ziegler & Co.

Patrick J. Haynes, Thurston Group Inc.

Sapna Tejwani Jethwa, Consonance Capital Partners LLC

Jonathan B. Lewis, Sheridan Capital Partners

Michele E. McHale, Plante Moran

John L. Pouschine, Pouschine Cook Capital Management LLC

Richard J. Zall, Proskauer Rose LLP

Faculty | Schedule | Registration | Location | Sponsorship | Audio Package |

There’s lots to be said about the attractions of investing in specialty physician practices -- 

  • Continuing high reimbursement rates
  • Numbers of physicians eager to strike out on their own
  • Opportunities for economies of scale

Still and all, healthcare investors know how log-jammed the sector has become.


Look at all the different practice areas, ranging from anesthesia to gastroenterology, from dermatology to ophthalmology -- and more.


Then look at the baffling legal complexities -- like antiquated laws that prohibit non-doctors from ownership of physician practices and of changing national laws like Medicare as well as state-specific regulatory regimes.


Register today to join more than 20 experts in debating what kinds of deals will generate the best returns in such a complex environment at The Capital Roundtable’s annual conference on Private Equity Investing in Specialty Physician Practices on Thursday, August 2, 2018.



Here Are Three Key Reasons Why You Should Join Us


  1. Hear the ins and outs of the sector -- including the latest technologies and regulatory updates.

  2. Hear wisdom from experienced investors who’ve successfully structured transactions and passed muster with regulators.

  3. Hear how healthcare management services organizations can help simplify processes for investors and physicians.



Here are some of the questions that the conference will answer -- 

  • What types of specialty physician practices offer the most attractive investment opportunities -- orthopedics, oncology, infertility, etc.

  • A specialty physician practice is like a law firm in that it’s typically owned by several partners. That ownership structure makes decision-making time consuming. How should the investor manage that?

  • What kind of generational makeup is optimal for such a practice -- how many physicians in their 50s and 60s versus ones that are younger?

  • What are the key trends when it comes to reimbursement rates by Medicare and private insurers? And how will those affect the profitability of specialty physician practices?

  • What changes among hospitals, insurers, and specialty physician practices are likely to affect the healthcare management services organizations landscape?

  • What kind of practice, if any, is better positioned to mitigate the reimbursement risk?

  • What if a large primary care provider is disappearing in a given market? How will that affect specialty physicians there?

  • Should the investor conduct diligence themselves, or should they use an outside source given the specialized nature of the target business?

  • After acquiring a specialty physician practice, what are some of the most important issues a healthcare management services organization should tackle?  Billing and collections, government reimbursement oversight, coding, revenue cycle management, strategic planning, and marketing?

  • To what extent should an investor pay attention to the state of evolution of the technology that the group employs, and what does that tell the investor?

  • Many hospitals, which historically have served as buyers of specialty physician groups, are under stress these days due to high leverage levels. How will this affect the investor’s exit prospect and strategy? Who else are logical buyers of these physician practices?

Register Now to Join Chairman Justin Unertl and More Than 20 Other Industry Experts


Mr. Unertl joined Excellere Partners in 2010 and is the co-head of the firm’s Provider Services healthcare vertical. He is currently a Board Observer at LucidHealth, a radiology physician practice platform and also serves on the Board of Directors at Biocare Medical and Medlogix. Mr. Unertl was previously active in several Excellere platforms that resulted in successful realizations including AxelaCare, Personable Insurance and PhyMed, an anesthesia practice management platform.


Excellere Partners is a Denver-based private equity firm with $1.36 billion of capital across three funds, and specializes in partnering with entrepreneurs and management teams. The firm employs a proven research-driven, top down investment strategy, and supports its entrepreneurs and management teams with a proprietary value creation process designed to enhance corporate and operational infrastructure for scalability and growth. The firm’s targeted industry sectors include healthcare services and products; energy, power and infrastructure products and services; industrial technology, specialty chemicals and services; and business services.

Prior to joining Excellere, Mr. Unertl was an operating executive with Arrowhead Health, a multi-specialty physician practice where he served as its chief financial officer and also carried business development responsibilities. He began his career in leveraged finance at Freeport Financial and GE Capital, with a focus on lower middle-market private equity buyouts.

Mr. Unertl earned a Finance degree from the University of Wisconsin.



 Recent Middle-Market PE Specialty Physician Practice Deals


  • Frazier Healthcare Partners and Princeton Ventures acquired CORE Institute, an orthopedic practice.

  • Waud Capital Partners invested in Minnesota Eye Consultants to form United Vision Partners.

  • Candescent Partners acquired Southeastern Spine Institute.

  • Harvest Partners teamed with Varsity Healthcare Partners to recap EyeCare Services Partners Holdings LLC.

  • Shore Capital Partners acquired Georgia Eye Partners.

  • In addition, a few private equity-backed dermatology practices have been busy doing add-on deals, including CI Capital Partners-owned Epiphany Dermatology, Harvest Partners-backed Cosmetic Surgery, GTCR-backed Riverchase Dermatology and Cosmetic Surgery, and ABRY Partners-owned U.S. Dermatology Partners.

This Capital Roundtable conference is the ideal place to expand your network and open up pathways to future deals. The day’s agenda includes ample time to let you --

  • Meet fellow attendees and featured speakers
  • Enhance your personal database with valuable new connections
  • Share both ideas and business cards
  • Meet potential investment partners and clients

Keep in mind this conference is certain to fill up quickly, so you’ll want to register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Julie Berger today to confirm your attendance at 212-832-7300 ext. 0 or


 Who Should Attend


Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, BDC, and Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants, & Other Advisors Who Support Them.




We look forward to having you join us on Thursday, August 2, 2018.


Conference Organizers


This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community.  For more information about The Capital Roundtable’s 30 annual conferences and other events and programs, please visit




 Speaking & Business Development Opportunities


We offer excellent speaking, marketing, and business development opportunities to reach the middle‑market private equity community. For more details, please contact Kellie Green or Claire Notton at 212-832-7300 or by email at or




Have a Question?


Please contact Julie Berger at or 212-832-7300 ext. 0.




Who We Are


This Capital Roundtable conference in midtown, New York City, is all-business, all-targeted, all-designed to be a completely focused day of practical information and revealing insights. You’ll gain valuable insights from --

  • Three informative panel discussions
  • Two revealing keynote presentations
  • Real-world perspectives from PE investors
  • Industry outlooks from noted sector experts
  • War stories and lessons learned from experienced hands

^ Back to Top ^


Chaired By

  • Justin Unertl, Principal, Excellere Partners


Hosted By

  • Burt Alimansky, Chairman & CEO, The Capital Roundtable


  • Fritz Buerger, Managing Director, William Blair & Co. LLC
  • Andrew R. Colbert, Managing Director, B. C. Ziegler & Co.
  • Patrick J. Haynes, Chairman, Thurston Group Inc.
  • Sapna Tejwani Jethwa, Vice President, Consonance Capital Partners LLC
  • Jonathan B. Lewis, Partner, Sheridan Capital Partners
  • Michele E. McHale, Partner, Plante Moran
  • John L. Pouschine, Managing Member, Pouschine Cook Capital Management LLC
  • Richard J. Zall, Partner, Proskauer Rose LLP

^ Back to Top ^



  • TBA


^ Back to Top ^


Space at this conference is limited, so register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Julie Berger today to confirm your attendance at 212-832-7300 ext. 0 or


Please note that The Capital Roundtable limits the number of registrants from a single firm to three.


  • Best Rate -- Early Registration -- Save $400 off the standard fee of $1495 when you register by Friday, June 8. Just $1095.


  • Incentive Registration -- save $200 off the standard fee!
    Register by Friday, June 29, and the fee for the conference is $1295.


  • Conference Rate -- $1,495 increasing to $1,595 day of conference, space permitting.


  • Group Rate -- $995 each, when you register two or more people to attend from the same company.


Register Now


You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 747 Third Avenue, Suite 200, New York, NY 10017.

Have a special question? Please contact Julie Berger at or 212-832-7300 ext. 0.


From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change.  We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.

^ Back to Top ^


Midtown, NYC

^ Back to Top ^

Audio Package

Can't attend but want to hear the program? You can buy the audio package along with the handouts. Purchase the audio package online now.

^ Back to Top ^


We offer excellent marketing and business development opportunities to reach the middle‑market private equity community. For more details, please contact Claire Notton at 212-832-7300 ext.117, or by email at


^ Back to Top ^